Hoxworth Hosts 5th Annual Hero2Hero Blood Drive
Hoxworth Blood Center will be hosting the fifth annual Hero2Hero Blood Drive in honor of Veterans Day Monday, Nov. 11, through Wednesday, Nov. 13. Donors will have the opportunity to be a local hero by sending a piece of home to our heroic troops stationed in Afghanistan.
Hero2Hero blood donations can be made at any of Hoxworths eight Neighborhood Donor Centers in the Tristate. For each blood donation collected, Hoxworth will send a holiday-care package loaded with Cincinnati favorites donated by its sponsors: P&G, Skyline Chili, Gold Star Chili, Cincinnati Magazine, Cincinnati Bengals, KIND, LaRosas and Montgomery Inn. Holiday cards will be available for donors to sign and be included in the care packages.
In addition, Hoxworth will once again be partnering with Operation: Thank You, a local organization that supports military troops and their families.
For more information, visit www.hoxworth.org/hero2hero. To schedule an appointment to donate, call 513-451-0910. Walk-ins are welcome.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.